Building Antigens for the Future
Existing structure-based antigen discovery efforts rely on traditional protein engineering techniques that are low-throughput, relying often on prolines and cysteines. We use next-generation computational design, structural characterization, and in vitro and in vivo techniques to rapidly generate and optimize antigens for use as vaccine candidates across a wide range of vaccine platforms.